Badania kliniczne, które rekrutują lub wkrótce zaczną rekrutację w ośrodkach w mieście Lublin. Najwięcej badań dotyczy: rak płuca, chłoniak, białaczka, nieswoiste zapalenia jelit.
432 badania: 402 rekrutują, 30 wkrótce zacznie.
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
+20Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
+15ContraBand™: Safety & Feasibility Study (RM-20-01)
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
+6A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
+3Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
+18A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
A Beta-only IL-2 ImmunoTherapY Study
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
+5A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
+4(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
+7A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
+20A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
+3Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
+39A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
+9Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
Resorbable Magnesium Scaffolds Registry
Secukinumab Open Label Roll-over Extension Protocol
+16Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
+39Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
+16A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
+2A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
+10Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
+3International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
+13A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are…
+14Pan Tumor Rollover Study
+30Zadzwoń i porozmawiaj z doradcą ds. badań klinicznych. Sprawdzimy w rejestrach, do których badań możesz się kwalifikować.
Nie udzielamy porad ani konsultacji medycznych. Pomagamy znaleźć badanie i skontaktować się z ośrodkiem.
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 3 października 2026.